Compare $CTMX vs $STTK | Chartloom

Compare

$CTMX vs $STTK

CytomX Therapeutics Inc · Shattuck Labs Inc

CTMX

CytomX Therapeutics Inc

STTK

Shattuck Labs Inc

Compare $CTMX vs $STTK

Comparing CytomX Therapeutics Inc and Shattuck Labs Inc

CTMXCytomX Therapeutics Inc

STTKShattuck Labs Inc

CTMXCytomX Therapeutics Inc

Market cap

$559M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

32.52x

Rev growth (TTM)

-87.0%

YTD performance

-39.5%

52W performance

-23.7%

FCF yield

-14.8%

STTKShattuck Labs Inc

Market cap

$540M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.6%

YTD performance

60.9%

52W performance

149.8%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CTMX

STTK

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

STTK

Shattuck Labs Inc

Market Cap

CTMX$559M

STTK$540M

Enterprise Value

CTMX$542M

STTK$476M

Price

CTMX$2.57

STTK$5.97

P/E Ratio

CTMXN/A

STTKN/A

P/S Ratio

CTMX30.57x

STTK539.51x

EV/Sales

CTMX29.63x

STTK476.21x

EV/EBITDA

CTMX22.17x

STTK0.00x

P/B Ratio

CTMX1.85x

STTK3.20x

P/FCF Ratio

CTMXN/A

STTKN/A

EV/FCF

CTMX-6.55x

STTK-11.55x

PEG Ratio

CTMXN/A

STTKN/A

Forward P/E (NTM)

CTMXN/A

STTKN/A

Forward P/S (NTM)

CTMX32.52x

STTKN/A

Revenue (TTM)

CTMX$18M

STTK$1M

Revenue Growth (YoY)

CTMX-87.0%

STTK-66.6%

Forward Rev Growth

CTMX35.7%

STTK118.7%

Gross Margin (TTM)

CTMX0.0%

STTK0.0%

Operating Margin (TTM)

CTMX0.0%

STTK0.0%

EBITDA Margin (TTM)

CTMX-471.6%

STTK-5212.2%

Net Margin (TTM)

CTMX-451.6%

STTK-5256.8%

FCF Margin (TTM)

CTMX-452.1%

STTK-4124.0%

Net Income (TTM)

CTMX$-83M

STTK$-53M

FCF (TTM)

CTMX$-83M

STTK$-41M

EPS (TTM)

CTMX-$0.38

STTK-$0.41

ROE (TTM)

CTMX-3846.0%

STTK-4357.0%

ROA (TTM)

CTMX-3033.0%

STTK-4090.0%

ROIC (TTM)

CTMX-3846.0%

STTK-4357.0%

Cash

CTMX$17M

STTK$63M

Debt

CTMX$0

STTK$0

Net Cash/Debt

CTMX$17M

STTK$63M

Current Ratio (TTM)

CTMX9.36x

STTK27.59x

Quick Ratio (TTM)

CTMX9.25x

STTK26.94x

Debt/Equity (TTM)

CTMX0.00x

STTK0.00x

Debt/Assets (TTM)

CTMX0.0%

STTK0.0%

Interest Coverage (TTM)

CTMXN/A

STTKN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

STTK0.00x

Beta

CTMX2.26

STTK0.98

52W Performance

CTMX-23.7%

STTK149.8%

YTD Performance

CTMX-39.5%

STTK60.9%

% from 52W High

CTMX-68.7%

STTK-28.3%

% from 52W Low

CTMX5.8%

STTK251.2%

Asset Turnover (TTM)

CTMX0.07x

STTK0.01x

FCF Yield (TTM)

CTMX-14.8%

STTK-7.6%

Earnings Yield (TTM)

CTMX-14.8%

STTK-9.7%

Dividend Yield (TTM)

CTMXN/A

STTKN/A

Rule of 40

CTMX-539.1

STTK-4,190.6

EV/GP/RG

CTMXN/A

STTKN/A

Ticker research

View CTMX research View STTK research

Metric	CTMX CytomX Therapeutics Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$559M	$540M
Enterprise Value	$542M	$476M
Price	$2.57	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	30.57x	539.51x
EV/Sales	29.63x	476.21x
EV/EBITDA	22.17x	0.00x
P/B Ratio	1.85x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	32.52x	N/A
Revenue & Growth
Revenue (TTM)	$18M	$1M
Revenue Growth (YoY)	-87.0%	-66.6%
Forward Rev Growth	35.7%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-471.6%	-5212.2%
Net Margin (TTM)	-451.6%	-5256.8%
FCF Margin (TTM)	-452.1%	-4124.0%
Net Income (TTM)	$-83M	$-53M
FCF (TTM)	$-83M	$-41M
EPS (TTM)	-$0.38	-$0.41
ROE (TTM)	-3846.0%	-4357.0%
ROA (TTM)	-3033.0%	-4090.0%
ROIC (TTM)	-3846.0%	-4357.0%
Financial Health
Cash	$17M	$63M
Debt	$0	$0
Net Cash/Debt	$17M	$63M
Current Ratio (TTM)	9.36x	27.59x
Quick Ratio (TTM)	9.25x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.98
52W Performance	-23.7%	149.8%
YTD Performance	-39.5%	60.9%
% from 52W High	-68.7%	-28.3%
% from 52W Low	5.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.01x
FCF Yield (TTM)	-14.8%	-7.6%
Earnings Yield (TTM)	-14.8%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CTMX research	View STTK research

Valuation

P/S Ratio

CTMX

30.57x

STTK

539.51x

EV/FCF

STTK

-11.55x

CTMX

-6.55x

Growth & revenue

Revenue Growth TTM

STTK

-66.6%

CTMX

-87.0%

Forward Revenue Growth

STTK

118.7%

CTMX

35.7%

Profitability & performance

Gross Margin

CTMX

0.0%

STTK

0.0%

ROE

CTMX

-3846.0%

STTK

-4357.0%

FCF Yield %

STTK

-7.6%

CTMX

-14.8%

52-Week Performance

STTK

149.8%

CTMX

-23.7%

Detailed metrics comparison

CTMX

CytomX Therapeutics Inc

STTK

Shattuck Labs Inc

Market Cap

CTMX$559M

STTK$540M

Enterprise Value

CTMX$542M

STTK$476M

Price

CTMX$2.57

STTK$5.97

P/E Ratio

CTMXN/A

STTKN/A

P/S Ratio

CTMX30.57x

STTK539.51x

EV/Sales

CTMX29.63x

STTK476.21x

EV/EBITDA

CTMX22.17x

STTK0.00x

P/B Ratio

CTMX1.85x

STTK3.20x

P/FCF Ratio

CTMXN/A

STTKN/A

EV/FCF

CTMX-6.55x

STTK-11.55x

PEG Ratio

CTMXN/A

STTKN/A

Forward P/E (NTM)

CTMXN/A

STTKN/A

Forward P/S (NTM)

CTMX32.52x

STTKN/A

Revenue (TTM)

CTMX$18M

STTK$1M

Revenue Growth (YoY)

CTMX-87.0%

STTK-66.6%

Forward Rev Growth

CTMX35.7%

STTK118.7%

Gross Margin (TTM)

CTMX0.0%

STTK0.0%

Operating Margin (TTM)

CTMX0.0%

STTK0.0%

EBITDA Margin (TTM)

CTMX-471.6%

STTK-5212.2%

Net Margin (TTM)

CTMX-451.6%

STTK-5256.8%

FCF Margin (TTM)

CTMX-452.1%

STTK-4124.0%

Net Income (TTM)

CTMX$-83M

STTK$-53M

FCF (TTM)

CTMX$-83M

STTK$-41M

EPS (TTM)

CTMX-$0.38

STTK-$0.41

ROE (TTM)

CTMX-3846.0%

STTK-4357.0%

ROA (TTM)

CTMX-3033.0%

STTK-4090.0%

ROIC (TTM)

CTMX-3846.0%

STTK-4357.0%

Cash

CTMX$17M

STTK$63M

Debt

CTMX$0

STTK$0

Net Cash/Debt

CTMX$17M

STTK$63M

Current Ratio (TTM)

CTMX9.36x

STTK27.59x

Quick Ratio (TTM)

CTMX9.25x

STTK26.94x

Debt/Equity (TTM)

CTMX0.00x

STTK0.00x

Debt/Assets (TTM)

CTMX0.0%

STTK0.0%

Interest Coverage (TTM)

CTMXN/A

STTKN/A

Net Debt/EBITDA (TTM)

CTMX0.00x

STTK0.00x

Beta

CTMX2.26

STTK0.98

52W Performance

CTMX-23.7%

STTK149.8%

YTD Performance

CTMX-39.5%

STTK60.9%

% from 52W High

CTMX-68.7%

STTK-28.3%

% from 52W Low

CTMX5.8%

STTK251.2%

Asset Turnover (TTM)

CTMX0.07x

STTK0.01x

FCF Yield (TTM)

CTMX-14.8%

STTK-7.6%

Earnings Yield (TTM)

CTMX-14.8%

STTK-9.7%

Dividend Yield (TTM)

CTMXN/A

STTKN/A

Rule of 40

CTMX-539.1

STTK-4,190.6

EV/GP/RG

CTMXN/A

STTKN/A

Ticker research

View CTMX research View STTK research

Metric	CTMX CytomX Therapeutics Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$559M	$540M
Enterprise Value	$542M	$476M
Price	$2.57	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	30.57x	539.51x
EV/Sales	29.63x	476.21x
EV/EBITDA	22.17x	0.00x
P/B Ratio	1.85x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	32.52x	N/A
Revenue & Growth
Revenue (TTM)	$18M	$1M
Revenue Growth (YoY)	-87.0%	-66.6%
Forward Rev Growth	35.7%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-471.6%	-5212.2%
Net Margin (TTM)	-451.6%	-5256.8%
FCF Margin (TTM)	-452.1%	-4124.0%
Net Income (TTM)	$-83M	$-53M
FCF (TTM)	$-83M	$-41M
EPS (TTM)	-$0.38	-$0.41
ROE (TTM)	-3846.0%	-4357.0%
ROA (TTM)	-3033.0%	-4090.0%
ROIC (TTM)	-3846.0%	-4357.0%
Financial Health
Cash	$17M	$63M
Debt	$0	$0
Net Cash/Debt	$17M	$63M
Current Ratio (TTM)	9.36x	27.59x
Quick Ratio (TTM)	9.25x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.26	0.98
52W Performance	-23.7%	149.8%
YTD Performance	-39.5%	60.9%
% from 52W High	-68.7%	-28.3%
% from 52W Low	5.8%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.01x
FCF Yield (TTM)	-14.8%	-7.6%
Earnings Yield (TTM)	-14.8%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-539.1	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CTMX research	View STTK research